Once-daily, steroid-free, prescription treatment for patients with eczema as young as 2 years of age
Mother and son laughing together Mother and son laughing together
Not actual patients/caregiver.

Strong enough for you, safe enough for your child too.

A once-daily, steroid-free eczema

(atopic dermatitis) treatment for patients
as young as 2 years old.
See the Results

Not actual patients/caregiver.

Why VTAMA cream?

VTAMA cream may help you or your child with eczema achieve clearer skin,
with itch relief as early as Day 2 reported in the pivotal studies by some patients.

The most common adverse reactions (incidence ≥1%) in patients with atopic dermatitis treated with VTAMA cream were upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

*Patients also achieved a ≥2-grade improvement from baseline in Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) score in 8 weeks.

MyVTAMA<sup>TM</sup> Savings Card

Clearer skin for the majority of patients for as little as $0.*

  • Commercially insured patients may pay as little as $0 and no more than $35.*

*Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.

Save Today
VTAMA In Play (VIP) logo

Become a VIP for clearer skin.
Sign up today.

VTAMA In Play (VIP) logo

VTAMA In Play is designed to support you in your journey to clearer skin.

Gain access to a wealth of resources tailored to help you manage your eczema effectively and confidently—including helpful tips and educational content.

VIP Updates Terms of Use

IMPORTANT SAFETY INFORMATION

Indications: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for:

Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).

Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Prescribing and Patient Information for VTAMA cream and discuss it with your doctor.

Back to top